STOCK TITAN

Glaukos (NYSE: GKOS) shares Q3 2025 results and supplemental summary

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Glaukos Corporation filed a current report describing how it shared its latest quarterly information with investors. On October 29, 2025, the company issued a press release announcing its financial results for the third quarter ended September 30, 2025, which is furnished as Exhibit 99.1. Glaukos also prepared a Quarterly Summary with supplemental business and financial information for the same period, furnished as Exhibit 99.2 and made available in the Financials & Filings section of its investor relations website. The company notes that these materials are furnished, not filed, under securities laws unless later specifically incorporated by reference.

Positive

  • None.

Negative

  • None.
0001192448false00011924482025-10-292025-10-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 29, 2025

Glaukos Corporation

(Exact name of registrant as specified in its charter)

Delaware

    

001-37463

    

33-0945406

(State or other jurisdiction

(Commission

(I.R.S. Employer

of incorporation)

File Number)

Identification No.)

One Glaukos Way

    

Aliso Viejo

California

92656

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (949) 367-9600

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class:

    

Trading Symbol

    

Name of each exchange on which registered:

Common Stock

GKOS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Item 2.02. Results of Operations and Financial Condition.

On October 29, 2025, Glaukos Corporation (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing.

Item 7.01. Regulation FD Disclosure.

A Quarterly Summary containing supplemental business and financial information for the Company’s third quarter ended September 30, 2025 is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Quarterly Summary is also available in the “Financials & Filings” section of the Company’s investor relations website at https://investors.glaukos.com.

The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

    

Description

99.1

 

Press Release of Glaukos Corporation, dated October 29, 2025

99.2

Quarterly Summary of Glaukos Corporation for the third quarter ended September 30, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

GLAUKOS CORPORATION
(Registrant)  

 

By:

/s/ Alex R. Thurman

 

 

Name:

Alex R. Thurman 

 

 

Title:

Senior Vice President & Chief Financial Officer

Date: October 29, 2025

FAQ

What did Glaukos (GKOS) report in its latest SEC filing?

Glaukos Corporation furnished an 8-K describing that it issued a press release with financial results for the third quarter ended September 30, 2025 and a separate Quarterly Summary with supplemental business and financial information for the same period.

Which period does Glaukos’ latest financial update cover?

The financial results and supplemental information relate to Glaukos Corporation’s third quarter ended September 30, 2025.

Where can investors find Glaukos (GKOS) Q3 2025 financial results?

The Q3 2025 financial results are included in a press release furnished as Exhibit 99.1 to the 8-K, and the company states this information is also part of its investor communications.

What is included in Glaukos’ Quarterly Summary for Q3 2025?

The Quarterly Summary, furnished as Exhibit 99.2, contains supplemental business and financial information for Glaukos Corporation’s third quarter ended September 30, 2025.

Is the Glaukos (GKOS) Q3 2025 Quarterly Summary available online?

Yes. Glaukos states that the Quarterly Summary for the third quarter ended September 30, 2025 is available in the “Financials & Filings” section of the company’s investor relations website at https://investors.glaukos.com.

Are Glaukos’ Q3 2025 exhibits considered filed or furnished?

The company specifies that the information in Item 2.02 and Item 7.01, including Exhibits 99.1 and 99.2, is furnished and not deemed filed for purposes of Section 18 of the Exchange Act, unless later expressly incorporated by reference.

Who signed Glaukos Corporation’s October 29, 2025 8-K?

The report was signed on behalf of Glaukos Corporation by Alex R. Thurman, Senior Vice President & Chief Financial Officer.

Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

6.52B
55.54M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO